These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 27272032)
1. Use of Statins and the Risk of Incident Diabetes: A Retrospective Cohort Study. Olotu BS; Shepherd MD; Novak S; Lawson KA; Wilson JP; Richards KM; Rasu RS Am J Cardiovasc Drugs; 2016 Oct; 16(5):377-90. PubMed ID: 27272032 [TBL] [Abstract][Full Text] [Related]
2. Statin-associated incident diabetes: a literature review. Park ZH; Juska A; Dyakov D; Patel RV Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689 [TBL] [Abstract][Full Text] [Related]
3. Risk of incident diabetes among patients treated with statins: population based study. Carter AA; Gomes T; Camacho X; Juurlink DN; Shah BR; Mamdani MM BMJ; 2013 May; 346():f2610. PubMed ID: 23704171 [TBL] [Abstract][Full Text] [Related]
4. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis. Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433 [TBL] [Abstract][Full Text] [Related]
5. Statins and new-onset diabetes: a retrospective longitudinal cohort study. Ma T; Tien L; Fang CL; Liou YS; Jong GP Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164 [TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
7. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study. Anyanwagu U; Mamza J; Donnelly R; Idris I Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436 [TBL] [Abstract][Full Text] [Related]
8. Statin users have an elevated risk of dysglycemia and new-onset-diabetes. Zigmont VA; Shoben AB; Lu B; Kaye GL; Clinton SK; Harris RE; Olivo-Marston SE Diabetes Metab Res Rev; 2019 Nov; 35(8):e3189. PubMed ID: 31125480 [TBL] [Abstract][Full Text] [Related]
9. Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial. Park JB; Jung JH; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW Trials; 2017 Oct; 18(1):501. PubMed ID: 29078817 [TBL] [Abstract][Full Text] [Related]
10. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study. Trias F; Pintó X; Corbella E; Suárez-Tembra M; Ruíz-García A; Díaz-Díaz JL; Sánchez-Ruíz-Granado E; Sarasa I; Martínez-Porqueras R; Rodríguez-Sánchez MA; Corbella X; Med Clin (Barc); 2022 Jun; 158(11):531-539. PubMed ID: 34517987 [TBL] [Abstract][Full Text] [Related]
11. Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study. Dave CV; Winterstein AG; Park H; Cook RL; Hartzema AG J Affect Disord; 2018 Oct; 238():542-546. PubMed ID: 29936394 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study. Yu JM; Chen WM; Shia BC; Wu SY Eur J Clin Pharmacol; 2023 May; 79(5):687-700. PubMed ID: 37010535 [TBL] [Abstract][Full Text] [Related]
13. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946 [TBL] [Abstract][Full Text] [Related]
14. Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan. Lin ZF; Wang CY; Shen LJ; Hsiao FY; Lin Wu FL Can J Diabetes; 2016 Jun; 40(3):264-9. PubMed ID: 26992286 [TBL] [Abstract][Full Text] [Related]
15. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors. Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577 [TBL] [Abstract][Full Text] [Related]
16. Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy. Wang KL; Liu CJ; Chao TF; Chen SJ; Wu CH; Huang CM; Chang CC; Wang KF; Chen TJ; Lin SJ; Chiang CE Am J Cardiol; 2014 Feb; 113(4):631-6. PubMed ID: 24360773 [TBL] [Abstract][Full Text] [Related]
17. Diabetes Secondary to Treatment with Statins. Laakso M; Kuusisto J Curr Diab Rep; 2017 Feb; 17(2):10. PubMed ID: 28155189 [TBL] [Abstract][Full Text] [Related]
19. Statins and renal disease progression, ophthalmic manifestations, and neurological manifestations in veterans with diabetes: A retrospective cohort study. Mansi IA; Chansard M; Lingvay I; Zhang S; Halm EA; Alvarez CA PLoS One; 2022; 17(7):e0269982. PubMed ID: 35862466 [TBL] [Abstract][Full Text] [Related]
20. Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea. Kim J; Lee HS; Lee KY Cardiovasc Diabetol; 2018 Dec; 17(1):155. PubMed ID: 30518364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]